Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Differential expression of Ago2-mediated microRNA signaling in adipose tissue is associated with food-induced obesity

Zhang H., Qiao L., Liu X., Han X., Kang J., Liu Y.

Animal Study on Type 2 Diabetes, published in FEBS Open Bio (2022) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
FEBS Open Bio (2022)
Reported sample size
—
Source database
Europe PMC
PMID
36062491
PMCID
PMC9527595
DOI
10.1002/2211-5463.13471

Abstract (original English)

Adipose tissue is a major component for the regulation of energy homeostasis by storage and release of lipids. As a core element of RNA-induced silencing complex, argonaute2 (Ago2) plays critical role in maintenance of systemic metabolic demand. Here, we show that high-fat-diet-fed mice exhibit an increase in body mass alongside systematic insulin resistance and altered rate of energy expenditure. Interestingly, Ago2 expression is associated with obesity and an increased amount of adipose tissue. Moreover, increased levels of Ago2 inhibited the expression of AMPKα by promoting its targeting by miR-148a, the most abundant microRNA in adipose tissues. Those results suggested that Ago2-miR-148a-AMPKα signaling pathway play an important function in the developing obesity and adiposity, and will further provide basic research data for the potential clinical treatment of obesity.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsMiceObesityLipidsMicroRNAsSignal TransductionAMP-Activated Protein KinasesArgonaute Proteins

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research